Related Attributes
Product details
Doxycycline Hyclate is a semi-synthetic tetracycline antibiotic. As a broad-spectrum antibiotic and bacteriostatic agent, Doxycycline Hyclate Powder is highly resistant to bacteria that cause respiratory tract infections, including Mycoplasma pneumoniae and Haemophilus influenzae.
As a broad-spectrum antibiotic and bacteriostatic agent, Doxycycline Hyclate Powder is highly resistant to bacteria that cause respiratory tract infections, including Mycoplasma pneumoniae and Haemophilus influenzae. addition,
Doxycycline Hyclate Raw Materials can also treat infections caused by Chlamydia, Rickettsia, and certain spirochetes and has antiprotozoal and deworming properties. and deworming properties.
Uses and functions of Doxycycline Hyclate Powder.
Doxycycline Hyclate is commonly used in the treatment of small animal infections caused by a number of different microorganisms, including Borrelia, Leptospira, Rickettsia, Chlamydia, Mycoplasma, Bartonella, and Bordetella. Broad-spectrum antibiotic, derivative of hygromycin. Broad-spectrum inhibitor of metalloproteinases in vivo.
Pharmacological Effects of Doxycycline Hyclate Powder.
Tetracycline antibiotics are bacteriostatic antibiotics that inhibit protein synthesis by reversibly binding to the 30S ribosomal subunit of susceptible bacteria, thereby preventing their binding to aminoacyltransfer RNA..It has also been suggested that tetracyclines reversibly bind to the 50S subunit and alter the permeability of the cell membrane of susceptible bacteria, and that they can also inhibit protein synthesis of mammalian cells at high concentrations.
Doxycycline Hyclate (Doxycycline hydrochloride hemiethanolate hemihydrate, WC2031) is a member of the tetracycline antibiotic group and is commonly used to treat a variety of infections. It is also an MMP inhibitor.
Production method of Doxycycline Hyclate Powder.
Doxycycline Hyclate is a semi-synthetic tetracycline antibiotic that penetrates cell membranes and binds to the 30S ribosomal subunit, interfering with tRNA/mRNA interactions and ultimately inhibiting protein synthesis.
As a broad-spectrum antibiotic and bacteriostatic agent, this antibiotic is very resistant primarily to bacteria that cause respiratory tract infections including Mycoplasma pneumoniae and Haemophilus influenzae. It also treats infections caused by Chlamydia, Rickettsia, and certain spirochetes and has antiprotozoal and deworming properties.
Why choose us?
HRK Factory
About Shipping
Pharmaceutical Intermediate manufacturers
©2022 Xi'an Henrikang Biotech Co., Ltd.,